Published • loading... • Updated
Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 7,500 Shares
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 7,500 Shares
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert Blum sold 7,500 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $70.24, for a total value of $526,800.00. Following the completion of the sale, the chief executive officer directly owned 377,820 shares of […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
